Compounds, their use and preparation

Details Compounds, their use and preparation Compounds, their use and preparation

2006-08-08

2006-08-08

McKenzie, Thomas C. (Department: 1624)

Organic compounds -- part of the class 532-570 series

Organic compounds

Unsubstituted hydrocarbyl chain between the ring and the -c-...

C544S349000, C544S373000, C546S133000, C548S466000, C548S509000, C514S218000, C514S249000, C514S253090, C514S305000, C514S414000, C514S415000

Reexamination Certificate

active

07087750

ABSTRACT:
The invention provides 2, 3-, 4- or 5-substituted-N1-(arylsulfonyl)indole and (heteroaryl)indole compounds of the general formula (I):in which Ar, R2, R3, R4and R5are as defined in the specification. The compounds bind to the 5-HT6receptor and are useful for the treatment and prophylaxis of disorders mediated by the 5-HT6receptor, such as obesity and CNS disorders.

REFERENCES:
patent: 6133287 (2000-10-01), Slassi et al.
patent: 6251893 (2001-06-01), Maddaford et al.
patent: 2002/0115670 (2002-08-01), Kelly et al.
patent: 2003/0045527 (2003-03-01), Briggs et al.
patent: 0812826 (1997-12-01), None
patent: 0 909 762 (1999-04-01), None
patent: 92/13856 (1992-08-01), None
patent: WO 9213856 (1992-08-01), None
patent: 96/03400 (1996-02-01), None
patent: WO 96/33171 (1996-10-01), None
patent: WO 9633171 (1996-10-01), None
patent: WO 9636611 (1996-11-01), None
patent: WO 9805315 (1998-02-01), None
patent: 99/47516 (1999-09-01), None
patent: WO 9947516 (1999-09-01), None
patent: 99/65906 (1999-12-01), None
patent: WO 9965492 (1999-12-01), None
patent: WO 9965906 (1999-12-01), None
patent: 00/34242 (2000-06-01), None
patent: WO 0232863 (2002-04-01), None
patent: WO 02 41889 (2002-05-01), None
patent: WO 0236562 (2002-05-01), None
Illi, Volker O., Synthesis (2), 136 (German) 1979.
Nyasse, Barthelemy; Grehn, Leif; Maia, Hernani L. S.; Monteiro, Luis S.; Ragnarsson, Ulf, Journal of Organic Chemistry, 64(19), 7135-7139, 1999.
Goulaouic-Dubois, Catherine; Guggisberg, Armin; Hesse, Manfred, Journal of Organic Chemistry, 60(18), 5969-72 (English) 1995.
U.S. Appl. No. 60/245,118, filed Nov. 2000, Kelly et al.
U.S. Appl. No. 60/298,834, Jun. 2001, Clark et al.
Bioorganic & Medicinal Chemistry Letters, vol. 10, No. 15, cover only.
Robichaud, A.J. et al, Ann. Reports Med. Chem., vol. 35, 2000, 11-19.
Dourish CT, Obes Res. Nov. 1995; 3 Suppl 4: 449S-462S, cited in Medline, Abstract PMID: 8697043.
Lindner, Mark D. et al JPET 307:682-691, 2003.
CAPLUS accession No. 1993:539117, Abstract Only.
CAPLUS accession No. 1996:736044, Abstract Only.
CAPLUS accession No. 1998:724128, Abstract Only.
CAPLUS accession No. 1993:495527, Abstract Only.
CAPLUS accession No. 1993:147461, Abstract Only.
CAPLUS accession No. 1999:550761, Abstract Only.
CAPLUS accession No. 1986:110010, Abstract Only.
CAPLUS accession No. 1979:450235, Abstract Only.
CAPLUS accession No. 1982:562734, Abstract Only.
CAPLUS accession No. 1986:186352, Abstract Only.
CAPLUS accession No. 1987:156217, Abstract Only.
CAPLUS accession No. 1993:101757, Abstract Only.
CAPLUS accession No. 1995:751092, Abstract Only.
CAPLUS accession No. 1998:265011, Abstract Only.
Isaac et al., “6-Bicyclopiperazinyl-1-arylsulfonylindoles and 6-Bicyclopiperidinyl-1-arylsulfonylindoles . . . ”, 2000, Bioorganic & Medicinal Chem. Letters, vol. 10;1719-1721.
Tsai et al., “N1-(Benzenesulfonyl)tryptamines as Novel 5-HT6 Antagonists”, 2000, Bioorganic & Medicinal Chem. Letters, vol. 10;2295-2299.
CAPLUS accession No. 1999:661842.
CAPLUS accession No. 1998:710510.
CAPLUS accession No. 1999:235586.
CAPLUS accession No. 2001:419497.
CAPLUS accession No. 2001:466985.
Lee et al., “5-HT6 Serotonin Receptor Binding Affinities of N1-Benzenesulfonyl . . . ”, 2000, Med. Chem, Res., vol. 10(4);230-242.
Tsai, et al.N1-(Benzenesulfonyl)tryptamines as Novel 5-HT6Antagonists. Bioorganic & Medicinal Chemistry Letters, vol. 10, No. 4, 2000, pp. 2295-2299.
Lee, et al.5-HT6Serotonin Receptor Binding Affinites of N1-Benzenesulfonyl and Related Tryptamines. Medicinal Chemistry Research, vol. 10, No. 4, 2000, pp. 230-242.
Bentley et al., “5-HT6 antisense oligonucleotide ICV affects rat performance in the water maze and feeding.” J Psychopharmacol Suppl A64, 1997, 255.
Bentley et al., “Effect of 5-HT6 antagonist Ro 04-6790 on food consumption in rats trained to a fixed feeding regime.” Br J Pharmacol. 1999 Suppl. 126, P66.
Hirst, “5-HT6 receptor and clinical positibilities, S12.2”Neuroscience in Orlando(Oct. 31-Nov. 10, 2002).
Meneses, “5-HT system and cognition”,Neurosci. Biobehav. Pharm. 23:1111-1125 (1999).
Rogers et al., Cognitive Enhancement Effect of Selective 5-HT6antagonist SB 271046,Br. J. Pharmac., 17:22P (1999).
Ruat et al. Biochem. Biophys. Res. Commun. 1993, 193 (1) 268-276.
Sakamoto, et al. Condensed heteroaromatic ring systems. XIII. One-step synthesis of 2-substituted 1-methylsulfonylindoles from N-(2-halophenyl)methanesulfonamides. Chem. Pharm. Bull., 1988, vol. 36, No. 4, pp. 1305-1308.
Sebben et al., NeuroReport 5, 2553-2557 (1994).
Williams et al., Annual Reports in Medicinal chemistry, D. Robertson, ed., vol. 36, pp. 1-5, Academic Press (2001).

Affiliated with

Also associated with

Rating

Compounds, their use and preparation does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Compounds, their use and preparation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compounds, their use and preparation will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3616513